- Home
- Publications
- Publication Search
- Publication Details
Title
Transglutaminase inhibitors: a patent review
Authors
Keywords
-
Journal
EXPERT OPINION ON THERAPEUTIC PATENTS
Volume 26, Issue 1, Pages 49-63
Publisher
Informa Healthcare
Online
2015-11-12
DOI
10.1517/13543776.2016.1115836
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- An unprecedented dual antagonist and agonist of human Transglutaminase 2
- (2015) Michael C. Yi et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Inhibitors of tissue transglutaminase
- (2015) Jeffrey W. Keillor et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Acyl transfer mechanisms of tissue transglutaminase
- (2014) Jeffrey W. Keillor et al. BIOORGANIC CHEMISTRY
- Discovery of Potent and Specific Dihydroisoxazole Inhibitors of Human Transglutaminase 2
- (2014) Cornelius Klöck et al. JOURNAL OF MEDICINAL CHEMISTRY
- Tissue transglutaminase: An emerging target for therapy and imaging
- (2013) Markus Pietsch et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Cysteamine: an old drug with new potential
- (2013) Martine Besouw et al. DRUG DISCOVERY TODAY
- Transglutaminase 2 reprogramming of glucose metabolism in mammary epithelial cells via activation of inflammatory signaling pathways
- (2013) Santosh Kumar et al. INTERNATIONAL JOURNAL OF CANCER
- Characterization of Heparin-binding Site of Tissue Transglutaminase
- (2012) Zhuo Wang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Discovery and Structure–Activity Relationship of Potent and Selective Covalent Inhibitors of Transglutaminase 2 for Huntington’s Disease
- (2012) Michael E. Prime et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Generation, Detection, and Effects of Reactive Drug Metabolites
- (2012) Andrew V. Stachulski et al. MEDICINAL RESEARCH REVIEWS
- Site-specific protein propargylation using tissue transglutaminase
- (2012) Claudio Gnaccarini et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Irreversible 4-Aminopiperidine Transglutaminase 2 Inhibitors for Huntington's Disease
- (2012) Michael E. Prime et al. ACS Medicinal Chemistry Letters
- SAR Development of Lysine-Based Irreversible Inhibitors of Transglutaminase 2 for Huntington's Disease
- (2012) John Wityak et al. ACS Medicinal Chemistry Letters
- Transglutaminase 2 and Its Role in Pulmonary Fibrosis
- (2011) Keith C. Olsen et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Recent advances in the development of tissue transglutaminase (TG2) inhibitors
- (2011) E. Badarau et al. AMINO ACIDS
- Transglutaminase 2: A molecular Swiss army knife
- (2011) Soner Gundemir et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Acylideneoxoindoles: A new class of reversible inhibitors of human transglutaminase 2
- (2010) Cornelius Klöck et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Potential of transglutaminase 2 as a therapeutic target
- (2010) Daniela Caccamo et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Redox Regulation of Transglutaminase 2 Activity
- (2010) Jorunn Stamnaes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Potent transglutaminase inhibitors, aryl β-aminoethyl ketones
- (2009) Shoichiro Ozaki et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Transglutaminase inhibition ameliorates experimental diabetic nephropathy
- (2009) Linghong Huang et al. KIDNEY INTERNATIONAL
- Transglutaminases and Disease: Lessons From Genetically Engineered Mouse Models and Inherited Disorders
- (2009) Siiri E. Iismaa et al. PHYSIOLOGICAL REVIEWS
- Synthesis of potent water-soluble tissue transglutaminase inhibitors
- (2008) Martin Griffin et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Extracellular Transglutaminase 2 Is Catalytically Inactive, but Is Transiently Activated upon Tissue Injury
- (2008) Matthew Siegel et al. PLoS One
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started